# Neuramis® Volume Lidocaine for Volume Augmentation in the Mid-Face

> **NCT03754413** · NA · COMPLETED · sponsor: **Medy-Tox** · enrollment: 236 (actual)

## Conditions studied

- Mid Face Volume Loss

## Interventions

- **DEVICE:** experimental
- **DRUG:** comparator

## Key facts

- **NCT ID:** NCT03754413
- **Lead sponsor:** Medy-Tox
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-29
- **Primary completion:** 2020-03-09
- **Final completion:** 2020-03-09
- **Target enrollment:** 236 (ACTUAL)
- **Last updated:** 2021-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03754413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03754413, "Neuramis® Volume Lidocaine for Volume Augmentation in the Mid-Face". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03754413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*